5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Hospital Mater Dei's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 5.46%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Hospital Mater Dei's 5-Year ROIIC % or its related term are showing as below:
BSP:MATD3's 5-Year ROIIC % is ranked better than 54.6% of 533
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs BSP:MATD3: 5.46
Hospital Mater Dei (BSP:MATD3) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Hospital Mater Dei 5-Year ROIIC % Related Terms
Hospital Mater Dei 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: 5-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei 5-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Hospital Mater Dei (BSP:MATD3) has a 5-Year ROIIC % of 5.46 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Hospital Mater Dei and its competitors. According to the industry distribution chart, Hospital Mater Dei ranks #242 out of 533 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is Hospital Mater Dei's 5-Year ROIIC % too high?
Hospital Mater Dei's current 5-Year ROIIC % is 5.46. The Healthcare Providers & Services industry median 5-Year ROIIC % is 3.46. Hospital Mater Dei's value of 5.46 is 57.8% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #242 out of 533 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's 5-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #242 out of 533 companies for 5-Year ROIIC %. This puts Hospital Mater Dei in the upper half of its industry. The industry median 5-Year ROIIC % is 3.46. Hospital Mater Dei's value of 5.46 is 57.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 533 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current 5-Year ROIIC % of 5.46 is 57.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current 5-Year ROIIC % is 5.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.86, compared to a current price of R$4.84 — trading 17.4% below its estimated fair value. The current 5-Year ROIIC % is 5.46 and 57.8% above the Healthcare Providers & Services industry median of 3.46. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current 5-Year ROIIC % is 5.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.84 is trading 17.4% below its estimated GF Value™ of R$5.86.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
5-Year ROIIC %: 5.46
GF Value™: R$5.86 vs. price of R$4.84 (17.4% below fair value)
Industry Position: 57.8% above the Healthcare Providers & Services median (#242 of 533)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
